Astrazeneca has become the first UK-listed company to achieve a market valuation of £200bn, a landmark achievement for both the pharmaceutical giant and the London Stock Exchange, as investors have ...

UK jobless rate has dropped to 4.2%, but growth in regular pay slows to 5.4%. BofA: US recession is top 'tail risk' in ...

Seismic events or a shift in valuations are likely necessary for more UK stocks to be worth £200bn, analysts have said.

Pfizer Inc., which has a facility in Groton, raised its profit expectations for the year, citing new cancer drugs, as it seeks to dig out of a COVID-related hole in sales. The New York-based ...

Lofty expectations for continuing sales of vaccines and antivirals have fallen short, sending Pfizer's stock price tumbling ...

Dr Hamish Graham, Pfizer Healthcare Hub: London manager, said ... a global network of innovation hubs that the company has in New York, Berlin, Tel Aviv, Stockholm, Sydney and Toronto.

Healthcare company Pfizer (PFE) has been working frantically on new potentially winning cures since the COVID-19 vaccine’s impact started to dwindle. And it may be one step closer to a new such ...

While the COVID-19 pandemic is an increasingly distant memory for most investors, Pfizer (NYSE: PFE) has struggled to move past the overhang of record vaccine sales and earnings in 2021 and 2022.

Pfizer Inc. reported positive data Monday from ... Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.

So we decided to settle with that. Q: What is Pfizer getting from its $43 billion purchase of cancer drugmaker Seagen? Seagen is the leading company in a new technology that is called ADC ...

WASHINGTON (AP) — Pfizer’s CEO Albert Bourla is trying to ... Bourla spoke with The Associated Press about the company’s new focus on specialty cancer drugs and obesity treatments.